UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Translational psychiatry, 2012-03, Vol.2 (3), p.e94-e94

2012

Volltextzugriff (PDF)

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Translational psychiatry, 2012-03, Vol.2 (3), p.e94-e94

2012

Volltextzugriff (PDF)

Identification of a biological signature for schizophrenia in serum

Molecular psychiatry, 2012-05, Vol.17 (5), p.494-502

2012

Volltextzugriff (PDF)

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum

Molecular psychiatry, 2010-11, Vol.15 (11), p.1088-1100

2010

Volltextzugriff (PDF)

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients

Molecular psychiatry, 2011-08, Vol.16 (8), p.848-859

2011

Volltextzugriff (PDF)

Psychotherapeutic work with older patients

Nervenarzt, 2014-11, Vol.85 (11), p.1345-1351

2014

Volltextzugriff (PDF)

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

Molecular psychiatry, 2010-02, Vol.15 (2), p.118-119

2010

Volltextzugriff (PDF)

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression

Journal of Neural Transmission, 2007-08, Vol.114 (8), p.1055-1063

2007

Volltextzugriff (PDF)

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Molecular psychiatry, 2008-12, Vol.13 (12), p.1118-1128

2008

Volltextzugriff (PDF)

THE BINOCULAR DEPTH INVERSION ILLUSION TEST – A BASIC MEASURE OF PERCEPTUAL INTEGRATION

Schizophrenia research, 2014-04, Vol.153, p.S39-S39

2014

Volltextzugriff (PDF)

Body Weight, the Tumor Necrosis Factor System, and Leptin Production during Treatment with Mirtazapine or Venlafaxine

Pharmacopsychiatry, 2002-11, Vol.35 (6), p.220-225

2002

Volltextzugriff (PDF)

Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report

Pharmacopsychiatry, 2008-05, Vol.41 (3), p.115-116

2008

Volltextzugriff (PDF)

Differential effects on T-cell function following exposure to serum from schizophrenia smokers

Molecular psychiatry, 2010-04, Vol.15 (4), p.364-371

2010

Volltextzugriff (PDF)

Psychotherapeutische Arbeit mit älteren Patienten

Nervenarzt, 2014-11, Vol.85 (11), p.1345-1351

2014

Volltextzugriff (PDF)

Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings

Pharmacopsychiatry, 2010-07, Vol.43 (5), p.196-197

2010

Volltextzugriff (PDF)

P03-156 Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia: A double-blind, randomised placebo-controlled clinical trial

European psychiatry, 2009, Vol.24, p.S1155-S1155

2009

Volltextzugriff (PDF)

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Neuropsychopharmacology, 2004-11, Vol.29 (11), p.2108-2114

2004

Volltextzugriff (PDF)

S39-02 Antipsychotic effects of cannabidiol

European psychiatry, 2009, Vol.24, p.S207-S207

2009

Volltextzugriff (PDF)

Cessation of Complex Visual Hallucinations during Treatment with Mirtazapine

Pharmacopsychiatry, 2007-03, Vol.40 (2), p.82-83

2007

Volltextzugriff (PDF)

S06-02 Functional aspects of the endocannabinoid system in schizophrenia

European psychiatry, 2009, Vol.24, p.S32-S32

2009

Volltextzugriff (PDF)

P.3.f.001 Does anandamide elevation in cerebrospinal fluid protect against transition into frank psychosis?

European neuropsychopharmacology, 2008, Vol.18, p.S474-S474

2008

Volltextzugriff (PDF)

S.08.04 Cannabidiol as antipsychotic

European neuropsychopharmacology, 2008, Vol.18, p.S171-S171

2008

Volltextzugriff (PDF)

Cannabidiol as an antipsychotic agent

European psychiatry, 2007-03, Vol.22, p.S21-S21

2007

Volltextzugriff (PDF)

Antibodies to infectious agents in individuals with recent onset schizophrenia

European archives of psychiatry and clinical neuroscience, 2004-02, Vol.254 (1), p.4-8

2004

Volltextzugriff (PDF)

Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study

Fortschritte der Neurologie, Psychiatrie, 2007-04, Vol.75 (4), p.211

2007

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(168)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Identification of a biological signature for schizophrenia in serum

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients

Psychotherapeutic work with older patients

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

THE BINOCULAR DEPTH INVERSION ILLUSION TEST – A BASIC MEASURE OF PERCEPTUAL INTEGRATION

Body Weight, the Tumor Necrosis Factor System, and Leptin Production during Treatment with Mirtazapine or Venlafaxine

Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report

Differential effects on T-cell function following exposure to serum from schizophrenia smokers

Psychotherapeutische Arbeit mit älteren Patienten

Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings

P03-156 Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia: A double-blind, randomised placebo-controlled clinical trial

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

S39-02 Antipsychotic effects of cannabidiol

Cessation of Complex Visual Hallucinations during Treatment with Mirtazapine

S06-02 Functional aspects of the endocannabinoid system in schizophrenia

P.3.f.001 Does anandamide elevation in cerebrospinal fluid protect against transition into frank psychosis?

S.08.04 Cannabidiol as antipsychotic

Cannabidiol as an antipsychotic agent

Antibodies to infectious agents in individuals with recent onset schizophrenia

Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study

Suchergebnisse filtern